Evidence map›Paper›PMID 41312347›Full record

ArticleFrontiers in neurology2025

Neuropsychiatric manifestations of Long COVID in India: a persistent problem 2.5 years after disease onset.

Anurag Kumar Singh, Kamlesh Kumar, Mahaveer Singh, Tushar Jagawat, Deepak Nathiya, Balvir Singh Tomar, Savita Jagawat, Millenia Jimenez, Melissa Lopez, Janet Miller and 1 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anurag Kumar SinghDepartment of Pharmacy Practice, National Institute of Medical Sciences and Research, Jaipur, Rajasthan, India.
Kamlesh KumarDepartment of Neurology, National Institute of Medical Sciences and Research, Jaipur, Rajasthan, India.
Mahaveer SinghDepartment of Endocrinology, National Institute of Medical Sciences and Research, Jaipur, Rajasthan, India.
Tushar JagawatDepartment of Psychiatry, National Institute of Medical Sciences and Research, Jaipur, Rajasthan, India.
Deepak NathiyaDepartment of Pharmacy Practice, National Institute of Medical Sciences and Research, Jaipur, Rajasthan, India.
Balvir Singh TomarInstitute of Pediatric Gastroenterology and Hepatology, National Institute of Medical Sciences and Research, Jaipur, Rajasthan, India.
Savita JagawatDepartment of Psychology, National Institute of Medical Sciences and Research, Jaipur, Rajasthan, India.
Millenia JimenezDavee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Melissa LopezDavee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Janet MillerNorthwestern Medicine, Chicago, IL, United States.
Igor J KoralnikDavee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Long COVID, also called post-acute sequelae of SARS-CoV-2 infection (PASC), is a multi-system syndrome affecting millions of people worldwide. Neuropsychiatric manifestations of Long COVID are particularly debilitating; however, they have not been reported in detail from India. Methods: This cross-sectional study compared the demographics, comorbidities, symptoms, and neuropsychiatric profiles of patients with Long COVID symptoms that began within 3 months of the initial SARS-CoV-2 infection and persisted for approximately 2.5 years at the time of evaluation. The study was conducted at NIMS University (Jaipur, Rajasthan, India). Results: Of 1,085 participants, 521 had COVID-19 pneumonia requiring hospitalization, while 564 had a mild initial respiratory presentation and were never hospitalized. On average 2.5 years after acute infection, our principal finding is that Long COVID differs based on initial disease severity. Post-hospitalization patients were older than the non-hospitalized group (43.24 vs. 36.15 years; Conclusion: Our study highlights differences in demographics and clinical presentation of Long COVID between post-hospitalization and non-hospitalized individuals in India. The high frequency of neurologic manifestations 2.5 years after disease onset underscores the need for early detection and targeted interventions.

Indexed as

IndiaLong COVIDneurologyPASCpost-acute sequelae of SARS-CoV-2 infection

Identifiers

PMID41312347
PMCPMC12646892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.